Average Co-Inventor Count = 2.82
ph-index = 6
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Immunogen, Inc. (17 from 255 patents)
2. Apoptosis Technology, Inc. (3 from 9 patents)
20 patents:
1. 11897961 - Anti-CD123 antibodies and conjugates and derivatives thereof
2. 11834498 - Biparatopic FR-alpha antibodies and immunoconjugates
3. 11396543 - Biparatopic FR-α antibodies and immunoconjugates
4. 11332535 - Anti-CD123 antibodies and conjugates and derivatives thereof
5. 10919969 - Anti-CD123 antibodies and conjugates and derivatives thereof
6. 10875925 - Anti-CD123 antibodies and conjugates and derivatives thereof
7. 10442865 - Methods of use of anti-CD123 antibodies and antigen-binding fragments thereof
8. 10077313 - Anti-CD123 antibodies and conjugates and derivatives thereof
9. 9238690 - Non-antagonistic EGFR-binding molecules and immunoconjugates thereof
10. 9233171 - Method of treatment of tumors that are resistant to EGFR antibody therapies by EGFR antibody cytotoxic agent conjugate
11. 9125896 - EGFR-binding molecules and immunoconjugates thereof
12. 8790649 - EGFR-binding molecules and immunoconjugates thereof
13. 7358088 - Peptides and compositions which modulate apoptosis
14. 7202346 - Antibodies to non-shed Muc1 and Muc16, and uses thereof
15. 7202024 - bbc3 Gene promoter and methods for identifying modulators of apoptosis and bbc3 gene expression using a bbc3 gene promoter